GlassScriptPhysician profile
Julie B Small
NPI 1124576616
$1,983.26
in general payments reported to CMS, 2019-2025
23 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $782 · 2022: $254 · 2023: $207 · 2024: $435 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $343.40 | 2021 | |
| Novocure INC. | $316.58 | 2021-2025 | Optune, Optune Gio |
| Novartis Pharmaceuticals Corporation | $203.98 | 2021-2025 | |
| Boston Scientific Corporation | $151.32 | 2021 | |
| Medtronic, INC. | $141.87 | 2024 | Signia |
| Astrazeneca Pharmaceuticals LP | $107.10 | 2022-2025 | Imfinzi |
| Abbvie INC. | $101.01 | 2021 | |
| Teleflex LLC | $78.46 | 2025 | Barrigel |
| Regeneron Healthcare Solutions, INC. | $68.53 | 2022-2025 | Libtayo |
| Merck Sharp & Dohme LLC | $62.75 | 2023-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Tersera Therapeutics LLC | $60.48 | 2023-2024 | Zoladex |
| Daiichi Sankyo INC. | $48.96 | 2024-2025 | Enhertu, Datroway |
| Bayer Healthcare Pharmaceuticals INC. | $47.21 | 2021 | |
| Blue Earth Diagnostics | $45.59 | 2025 | Posluma |
| Janssen Biotech, INC. | $41.06 | 2024 | Rybrevant |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $39.05 | 2021 | |
| Genentech USA, INC. | $23.50 | 2025 | Gazyva |
| Tolmar Pharmaceuticals, INC. | $21.39 | 2022 | |
| Telix Pharmaceuticals | $19.34 | 2023 | Illuccix |
| Accuray Incorporated | $17.82 | 2022 | |
| Sumitomo Pharma America, INC. | $17.27 | 2024 | Orgovyx |
| Ge Healthcare | $14.24 | 2022 | |
| Palette Life Sciences, INC. | $12.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.